Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gabapentin for post-viral parosmia
ISRCTN82171427Phase 3Recruiting
- Sponsor
- University College London
- Start
- Oct 2025
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, double-blind trial in Olfactory disorder comparing Gabapentin with Placebo (2 arms). Started Oct 2025; status: recruiting.
02
Drugs
gabapentin
03
Conditions
Olfactory disorder
Beyond the preview
Go deeper on ISRCTN82171427.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN82171427.